White blood cell counts or leukocytes could be a crucial indicator of COVID-19 severity in women, impacting treatment ...

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

People with shorter protective caps at the end of their chromosomes (called telomeres) may be more likely to develop ...

Shorter telomeres are linked to higher risks of stroke, dementia, and depression, but lifestyle factors may help counteract ...

A new study based on Women’s Health Initiative data suggests that a readily available and inexpensive clinical marker of ...

Leukocyte count is an independent predictor of future long COVID in postmenopausal women, according to study findings.

A new international study reveals that leukocyte count could be a key indicator in determining long-term Covid-19 effects in ...

The Activated Leukocyte Cell Adhesion Molecule (ALCAM), also known as CD166, is a protein that plays a crucial role in cell adhesion and communication. It is involved in various biological ...

Leukocyte cell-derived chemotaxin 2 (LECT2) is a protein that has garnered attention for its multifaceted roles in various physiological and pathological conditions, particularly in the context of ...

Higher levels of leukocytes – a form of white blood cell – are associated with more severe symptoms of long COVID among older ...

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people. A new study, however, suggests that it may now be easier to predict who is ...